A Phase 1, Placebo-controlled, Single-Ascending-Dose, Study of BIOPIN 6 in Healthy Adults
The purpose of this study is to evaluate the safety and blood levels of a medicine, naltrexone, contained within an implant in healthy volunteers age 18 to 65 years. To do this, the implant containing the drug will be inserted under the skin, left in place for 3 months and then removed.
100 项与 Drug Delivery Co. LLC 相关的临床结果
0 项与 Drug Delivery Co. LLC 相关的专利(医药)
100 项与 Drug Delivery Co. LLC 相关的药物交易
100 项与 Drug Delivery Co. LLC 相关的转化医学